Alzheimer's Disease Revealed By Reliable Digital Memory Assessments Alzheimer's disease (AD) research has advanced in detecting pathological changes through biomarkers, but cognitive measures lag in capturing early, subtle impairments. Traditional assessments designed for overt deficits are now outpaced by discoveries in episodic memory networks within the medial temporal lobe, which are
Tag: Alzheimer’s disease biomarker testing
Constructive Uses For Biomarker Testing In Dementia
Constructive Uses For Biomarker Testing In Dementia Overview The Investigating the Impact of Alzheimer’s Disease Diagnostics in British Columbia (IMPACT-AD BC) study aimed to evaluate the effects of Alzheimer’s disease (AD) cerebrospinal fluid (CSF) biomarker testing on medical decision-making, personal decision-making, and health system economics. This observational, longitudinal cohort study enrolled 149
